 Jennifer Sunshine |
APCO Worldwide has hired Booz Allen Hamilton healthcare consultant Jennifer Sunshine as a director in DC.
She handled knotty regulatory, issues and communications matters, spending more than four years guiding the State Exchange Group as it established parameters for local insurance exchanges and open enrollment.
Sunshine also supported BAH's Food and Drug Administration team on Congress' generic drug user fees amendment.
Prior to BAH, Sunshine served as senior health policy analyst at America's Health Insurance Plans, trade group for insurance companies, and policy & regulatory affairs manager at the Generic Pharmaceutical Assn.
Evan Kraus, global president, expects APCO healthcare clients will benefit from Sunshine's regulatory insights into the workings of drug companies, patient advocacy groups, associations and health plans.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
